Diabetes

In 2023, semaglutide emerged as the top-selling drug in the USA, generating $13.8 billion in sales.

New research shows that diabetes rates have doubled to 800 million adults, but over half remain untreated.

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related hospitalisations.

The researchers found that overeating triggers a rapid increase in norepinephrine, a key stress hormone. This, in turn, over activates the sympathetic nervous system.

Limiting sugar intake during early life, including in utero, may significantly reduce the risk of developing Type 2 diabetes and hypertension in adulthood.

Meal timings may be linked to chronic health conditions, including increased risk of diabetes, amongst people who work night shifts.

Dysregulation of certain amino and fatty acids in late pregnancy could influence the risk of developing Type 2 diabetes

25-year-old woman with Type 1 diabetes in China has successfully undergone a stem-cell therapy that enabled her to produce her own insulin, reducing her reliance on injections.